the aid library

Filter

10477

WHO Tanzania 2022 Annual Report

World Health Organisation (WHO) (2023) C_WHO

The Annual Report summarizes what has been achieved in the year 2022, how WHO supported the country priority, how WHO took the lead in health in bringing together partners to help the country achieve its strategic goals as a result be on track on its commitment on the SDG goals. The report also high ... more

Download

View PDF

Chinese Aid and Health at the Country and Local Level

Cruzatti, J., Dreher, A., and Matzat, J. AidData (2020) CC

We investigate whether and to what extent Chinese development finance affects infant mortality, combining 92 demographic and health surveys (DHS) for a maximum of 53 countries and almost 55,000 sub-national locations over the 2002-2014 period. We address causality by instrumenting aid with a set of ... more

External Link

WHO guideline on the prevention of female genital mutilation and clinical management of complications

World Health Organization WHO (2025) C_WHO

emale genital mutilation (FGM) comprises all procedures that involve the partial or total removal of external genitalia or other injury to the female genital organs for non-medical reasons; the procedure has no health benefits . Moreover, the removal of or damage to healthy genital tissue interferes ... more

External Link

Antimalarial drugs for treating and preventing malaria in pregnant and lactating women

Saito, M.; Gilder, M. E.; McGready, R. et al. (2018) C2

EXPERT OPINION ON DRUG SAFETY 2018, VOL. 17, NO. 11, 1129–1144. Malaria during and after pregnancy contributes significantly to maternal mortality and adverse fetal outcomes. While effective and safe antimalarial treatments are essential, quinine — an older, less effective drug — has long bee ... more

Download

View PDF

Extending the WHO scheme for external quality assessment of nucleic acid amplification testing for monitoring antimalarial drug resistance: meeting report, 14 July 2023

World Health Organization WHO (2025) C_WHO

WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ... more

External Link

NLM Malaria Screener

National Library of Medicine (NLM) Lister Hill National Center for Biomedical Communications (2021) C2

The NLM Malaria Screener is a mobile app developed by the U.S. National Library of Medicine to support the diagnosis of malaria through automated analysis of blood smear images. It uses smartphone microscopy and machine learning to detect malaria parasites in thin blood smears, helping health worker ... more

Download

View PDF

Malaria surveillance assessment toolkit

World Health Organization WHO (2022) C_WHO

Implementation reference guide. This Malaria Surveillance Assessment Toolkit implementation reference guide is a comprehensive reference document, as well as a step by-step guide. It aligns and adapts available tools into a single set of standardized tools, which can be used to conduct malaria surve ... more

Download

View PDF

A survey of users on the WHO insecticide susceptibility tube test kit

World Health Organization WHO (2024) C_WHO

The WHO susceptibility test kit has been extensively used for monitoring of insecticide resistance in disease vectors for many years. Over the years, users have reported issues with these kits and potential improvements to WHO in an ad-hoc manner. To systematically determine whether the reported iss ... more

Download

View PDF

Integrated Outbreak Analytics Toolkit

Global Outbreak Alerts Response Network GOARN (2025) CC

Integrated Outbreak Analytics (IOA) applies a multidisciplinary approach to understanding outbreak dynamics and to inform outbreak response. It aims to drive comprehensive, accountable, and effective public health and clinical strategies by enabling communities, and national and subnational health a ... more

Download

View PDF

Household air pollution and related health impacts: technical brief

World Health Organization WHO (2025) C_WHO

More than a quarter of the global population still cook meals over open fires and/or on simple stoves fuelled by firewood, agricultural waste, dried dung, charcoal, and coal. This practice results in the emission of harmful and dangerously high leve ... more

Download

View PDF

Guidelines for Use of the APCA African Palliative Outcome Scale

African Palliative Care Association APCA (2011) C2

The Guidelines for the Use of the APCA African Palliative Outcome Scale (POS) has been developed by the APCA, in collaboration with stakeholders, to help appropriately trained health practitioners and researchers across the region to utilise the APCA African POS in their work place (Powell et ... more

Download

View PDF

Epidemiological data analysis for the early warning alert and response network (EWARN) in humanitarian emergencies

World Health Organisation (WHO) (2019) C_WHO

The WHO handbook “Epidemiological Data Analysis for the Early Warning Alert and Response Network (EWARN) in Humanitarian Emergencies” explains how to collect, analyse, interpret, and share health data during crises such as conflicts or natural disasters. It is a practical guide for health and su ... more

External Link

Turning Waste into Wins: Cutting Emissions with Reverse Logistics

Logistics Cluster (2025) CC

This guide outlines a practical approach to estimating greenhouse gas emissions avoided by diverting waste from landfills through reverse logistics and reuse/recycling. It provides step-by-step guidance, emission factors, and a scenario tailored to humanitarian operations, along with suggestions on ... more

External Link

Leishmaniosis outreach posters

Stophleishmania.org (2023) C2

Website last accessed on 07.06.2023 Stopleishmania.org is an initiative of the VISAVET Health Surveillance Centre (UCM), the National Centre of Microbiology (ISCIII), the Animal Protection Centre (Madrid City Council) and the Directorate of Public Health (Regional Government of Madrid). This proj ... more

External Link

Burden of and Health Loss Due to the Effect of Maternal Hypertensive disorders in Ethiopia

Abebe, B.; Abera, M.; Sena, L. Ethiopian Journal of Health Development (2023) CC

Background: Worldwide, maternal hypertensive disorders complicate one in ten pregnancies. As a result of changes in the life styles of society, currently, it is becoming a common public life encounter. However, Ethiopia lacks comprehensive and comparable maternal hypertensive disorders, causing burd ... en and health loss to inform policy and practice. Objective: To describe the incidence and prevalence of maternal hypertensive disorders and deaths, Disability Adjusted Life Years, and Years Life Lost attributable to maternal hypertensive disorders in Ethiopia and its regional distributions from 1990 to 2019 as part of a collaborative Global Burden of Diseases, (2019) Study. Methods: The data for this study were collected from surveys, demographic surveillances, medical record reviews, health facility observations and interviews socio-demographic, health care service utilization, and other data sources such as case notifications, scientific literature, and unpublished data as per the Global Burden of Disease protocol and analysis techniques to produce national and regional estimates of maternal hypertensive disorders in Ethiopia. Cause of death ensemble modeling and Bayesian meta-regression disease modeling was employed to ascertain cause of death and morbidity. Each metric was estimated per 100,000 populations with a 95% uncertainty interval (UI). Results: In the last thirty years, in Ethiopia, , the incidence of maternal hypertensive disorders among young women was raised by 52,596 cases per 100,000 population [199,707 (95% UI 150,261-267,221) to 252,303 (95% UI 191,335-332,524)], while decreased among adolescent women from 67,206 (95% UI 46,887-90,883) to 64, 622 (95% UI; 47,587-84,664) per 100,000 population. The prevalence among women of reproductive age had increased from 94, 818 (95% UI 59,434-135,332) in 1990 to 138, 263 (95% UI 88,447-196,029) in 2019. Between 1990 and 2019, deaths attributable to maternal hypertensive disorders among adolescents and young women had increased by 1.5 and 1.17 times, respectively. In 2019, disability adjusted life years among adolescent, young women and women of reproductive age due to maternal hypertensive disorders was 8,493 (UI 95% 5,370-12,849), 21,812 (UI 95% 14,682-32,139) and 57,867 (UI 95% 41,751-79,165) respectively. The highest daily adjusted life years due to maternal hypertensive disorders had occurred among young women, 13,319 (UI 95% 8,592-19,931) which was higher than 1990 whereas the young women years of life lost had increased. Conclusions: Based on the finding, increasingly high new cases, prevalence and burden of maternal hypertensive disorders and significant health loss were observed in the last three decades in Ethiopia. Hence, prevention of cases, disabilities, deaths and health losses caused by maternal hypertensive disorders can be prevented by properly advocating lifestyle modifications with specifically designed age-specific interventions. On the top of continuing prevention efforts with newly devised magnesium sulphate administration in the new ANC initiative of the ministry, contextualized, need based, localized, and targeted interventions could be reconstituted. [Ethiop. J. Health Dev. 2023;37 (SI-2)] more

External Link

Factors associated with the disbursements of development assistance for health in low-income and middle-income countries, 2002–2017

Moitra , M.; Cogswell, I.; Maddison, E. et al. BMJ Global Health (2021) CC

Introduction In 2017, development assistance for health (DAH) comprised 5.3% of total health spending in lowincome countries. Despite the key role DAH plays in global health-spending, little is known about the characteristics of assistance that may be associated with committed assistance that is a ... more

Baseline Mapping of Neglected Tropical Diseases in Africa: The Accelerated WHO/AFRO Mapping Project

Rebollo M.P., Onyeze A.N., Tiendrebeogo A. et al The American Society of Tropical Medicine and Hygiene (2021) C2

ajtmh.20-1538 Volume 104, 6. Mapping is a prerequisite for effective implementation of interventions against neglected tropical diseases (NTDs). Before the accelerated World Health Organization (WHO)/Regional Office for Africa (AFRO) NTD Mapping Project was initiated in 2014, mapping efforts in man ... more

Download

View PDF

Impact of COVID-19 on the indigenous population of Brazil: a geo-epidemiological study

Alves J.D., Abade A.S., Peres W.P. et al. Cambridge University Press (2021) CC

This study aimed to analyze the geographical distribution of coronavirus disease 2019 (COVID-19) and to identify high-risk areas in space and time for the occurrence of cases and deaths in the indigenous population of Brazil. This is an ecological study carried out between 24 March and 26 October 20 ... more

External Link

Stunting as a Risk Factor of Soil-Transmitted Helminthiasis in Children: A Literature Review

Fauziah, N.; Ar-Rizqi, M.A.; Hana, S. Interdisciplinary Perspectives on Infectious Diseases (2022) CC

As a high-burden neglected tropical disease, soil-transmitted helminth (STH) infections remain a major problem in the world, especially among children under five years of age. Since young children are at high risk of being infected, STH infection can have a long-term negative impact on their life, i ... more

Download

View PDF

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc ... e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more